RxResults, a pharmacy benefits risk management company, has raised $4 million, according to a filing with the SEC.
The company, headed by CEO Terry Baskin and based in Little Rock, Arkansas, provides its clients with informatics-powered tools that seek to reduce cost and improve quality for pharmacy benefits for both insurers and their members, according to a description on its website.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It is also in a joint venture with the University of Arkansas Medical Sciences College of Pharmacy’s Evidence-Based Prescription Drug Program, which offers consulting services to self-funded employers, health plans and trust funds to lower prescription drug costs within their respective pharmacy benefit plans.
The company raised the $4 million through the sale of equity, debt and other securities in the states of Arkansas, Connecticut, Delaware, Florida, Georgia, Illinois, New Jersey, New York and South Carolina, according to a Form D filing.
The company has a specific eye on the self-insured market of employers with more than 5,000 workers.